ARCHIVES

Survivors With Gene Variant At More Risk For Heart Disease

This article is from The Cancer Letter archive.

Vol. 33 No. 6 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application

September 24, 1999

An Appreciation: Janet Rowley, “Translational Research Pioneer”

January 3, 2014

NSABP Submits Appeal To NIH To Reverse Cancellation Of P-4 Chemoprevention Trial.

August 10, 2007

AACR Completes List Of Symposia Chairpersons

April 22, 1988

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007